BACTERIAL ISOLATES AND THEIR SENSITIVITY PATTERNS IN PATIENTS WITH DIABETIC FOOT ULCERS
Main Article Content
Abstract
Objective: To determine the frequency of common microorganisms (bacterial isolates) and their sensitivity and resistance patterns in patients with diabetic foot ulcers
Materials and Methods: This descriptive cross-sectional study was conducted in the Department of Medicine, Khyber Teaching Hospital Peshawar from June 2020 to June 2021. Two hundred and thirty-eight diabetic patients with foot ulcers were included in the study. Deep wound swabs were collected and sent to the microbiology laboratory for culture and sensitivity. The sensitivity patterns of different organisms were identified.
Results: One hundred and thirty-four out of 238 (56.3%) patients were male, and the remaining 104 (43.7%) were female. The mean age of the patients in our study was 57.12±9.58 (32-80) years. Cultures were positive in 216 out of 238 (91%). Gram-negative organisms were 175 (81%), while 41 (19%) were gram-positive bacteria. The common bacteria were Escherichia coli 99 (45.8%), Pseudomonas aeruginosa 49 (22.7%), Staphylococcus aureus including methicillin-resistant staphylococcus aureus (MRSA) 36 (16.6%). The most effective antibiotics against gram-negative organisms were Meropenem (Sensitivity 97%), Amikacin (96%), Piperacillin-Tazobactam (95%), and Cefoperazone-Sulbactam (94%). The most effective antibiotics against Gram-Positive organisms were Vancomycin (Sensitivity 100%), Teicoplanin (100%), and Linezolid (95%). Antibiotics with higher rates of resistance included Doxycycline (89%), Clarithromycin (80%), and Co-Trimoxazole (78.7%).
Conclusion: Diabetic foot ulcers are frequently infected with a variety of organisms. Escherichia coli, Pseudomonas, and staphylococcus aureus are the primary (predominant) organisms. Meropenem, Amikacin, Cefoperazone-Sulbactam, and Piperacillin-Tazobactam Are The most effective antibiotics against Gram-Negative Bacteria, while Vancomycin, Teicoplanin, and Linezolid are effective against gram-positive bacteria.
Keywords:
Diabetes Mellitus, Foot Ulcer, Pus Culture, Bacteria, Antibiotic Sensitivity and Resistance
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles published in the Journal of Medical Sciences (JMS) are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under the CC BY 4.0 license, author(s) retain the ownership of the copyright publishing rights without restrictions for their content, and allow others to copy, use, print, share, modify, and distribute the content of the article even for commercial purposes as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers for this purpose. Appropriate attribution can be provided by simply citing the original article. The corresponding author has the right to grant on behalf of all authors, a worldwide license to JMS and its licensees in all forms, formats, and media (whether known now or created in the future), The corresponding author must certify and warrant the authorship and proprietorship and should declare that he/she has not granted or assigned any of the article’s rights to any other person or body.
The corresponding author must compensate the journal for any costs, expenses, or damages that the JMS may incur as a result of any breach of these warranties including any intentional or unintentional errors, omissions, copyright issues, or plagiarism. The editorial office must be notified upon submission if an article contains materials like text, pictures, tables, or graphs from other copyrighted sources. The JMS reserves the right to remove any images, figures, tables, or other content, from any article, whether before or after publication, if concerns are raised about copyright, license, or permissions and the authors are unable to provide documentation confirming that appropriate permissions were obtained for publication of the content in question.